Pontiano Kaleebu

Pontiano Kaleebu is a Ugandan physician, clinical immunologist, HIV/AIDS researcher, academic and medical administrator, who is the executive director of the Uganda Virus Research Institute.

He also concurrently serves as the director of the joint clinical research unit owned by the Medical Research Council (United Kingdom), the Uganda Virus Research Institute, and the London School of Hygiene & Tropical Medicine, located in Entebbe, Uganda, carrying on research in infectious, non-communicable and neglected diseases. Provided by Wikipedia
Showing 1 - 20 results of 44 for search 'Pontiano Kaleebu', query time: 0.03s Refine Results
  1. 1
    Hypertension persisting after pre-eclampsia: a prospective cohort study at Mulago Hospital, Uganda.

    Hypertension persisting after pre-eclampsia: a prospective cohort study at Mulago Hospital, Uganda. by Annettee Nakimuli, Alison M Elliott, Pontiano Kaleebu, Ashley Moffett, Florence Mirembe

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Prevalence and factors associated with overweight and obesity among patients with type 2 diabetes mellitus in Uganda—a descriptive retrospective study

    Prevalence and factors associated with overweight and obesity among patients with type 2 diabetes mellitus in Uganda—a descriptive retrospective study by Pontiano Kaleebu, Moffat Nyirenda, Salome Tino, Billy N Mayanja, Michael Charles Mubiru, Emmanuel Eling, Edward Ddumba

    Published 2020-11-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Contraceptive use, prevalence and incidence of pregnancy and associated factors among women participating in a vaccine preparedness cohort study in Masaka, Uganda, a retrospective secondary analysis

    Contraceptive use, prevalence and incidence of pregnancy and associated factors among women participating in a vaccine preparedness cohort study in Masaka, Uganda, a retrospective... by Sylvia Kusemererwa, Sheila Kansiime, Sarah Nakamanya, Elizabeth Mbabazi, Julie Fox, Sheena McCormack, Pontiano Kaleebu, Eugene Ruzagira

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Coreceptor and cytokine concentrations may not explain differences in disease progression observed in HIV-1 clade A and D infected Ugandans.

    Coreceptor and cytokine concentrations may not explain differences in disease progression observed in HIV-1 clade A and D infected Ugandans. by Edward Wright, Susan Mugaba, Paul Grant, Rosalind Parkes-Ratanshi, Lieve Van der Paal, Heiner Grosskurth, Pontiano Kaleebu

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial.

    Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. by Ben Gombe, Claire Streatfield, Lorna Leal, Solomon Opio, Sarah Joseph, Jonathan Weber, Jonathan Hare, Pontiano Kaleebu, Jennifer Serwanga

    Published 2022-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Unique genetic signatures in HIV-1 subtype A1 and A1D recombinant envelope glycoprotein distinguish contemporary transmitted/founder viruses from historical strains in East Africa

    Unique genetic signatures in HIV-1 subtype A1 and A1D recombinant envelope glycoprotein distinguish contemporary transmitted/founder viruses from historical strains in East Africa by Frank Kato, Frank Kato, Anne Kapaata, Ronald Galiwango, Ronald Galiwango, Angella Nakyanzi, Christian Ndekezi, Christian Ndekezi, Fortunate Natwijuka, Fortunate Natwijuka, Denis Omara, Denis Omara, Andrew Ekii Obuku, Brian Foley, Pontiano Kaleebu, Pontiano Kaleebu, Eunice Nduati, Sheila Nina Balinda, Sheila Nina Balinda

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Effect of HIV-1 subtypes on disease progression in rural Uganda: a prospective clinical cohort study.

    Effect of HIV-1 subtypes on disease progression in rural Uganda: a prospective clinical cohort study. by Deogratius Ssemwanga, Rebecca N Nsubuga, Billy N Mayanja, Frederick Lyagoba, Brian Magambo, Dave Yirrell, Lieve Van der Paal, Heiner Grosskurth, Pontiano Kaleebu

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis.

    Quality of life and associated factors among HIV positive patients after completion of treatment for Cryptococcal meningitis. by Jonathan Kitonsa, Julius Kiwanuka, Zacchaeus Anywaine, Sheila Kansiime, Kenneth Katumba, Namirembe Aeron, Justin Beardsley, Freddie Kibengo, Alastair Gray, Pontiano Kaleebu, Jeremy Day

    Published 2021-03-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission.

    HIV monoclonal antibodies: a new opportunity to further reduce mother-to-child HIV transmission. by Yegor Voronin, Lynne M Mofenson, Coleen K Cunningham, Mary G Fowler, Pontiano Kaleebu, Elizabeth J McFarland, Jeffrey T Safrit, Barney S Graham, William Snow

    Published 2014-04-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda.

    Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uga... by Jonathan Kitonsa, Rebecca Nsubuga, Yunia Mayanja, Julius Kiwanuka, Yofesi Nikweri, Martin Onyango, Zacchaeus Anywaine, Abu-Baker Ggayi, Freddie Mukasa Kibengo, Pontiano Kaleebu, Jeremy Day

    Published 2020-11-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naïve Ugandans.

    Host HLA B*allele-associated multi-clade Gag T-cell recognition correlates with slow HIV-1 disease progression in antiretroviral therapy-naïve Ugandans. by Jennifer Serwanga, Leigh Anne Shafer, Edward Pimego, Betty Auma, Christine Watera, Samantha Rowland, David Yirrell, Pietro Pala, Heiner Grosskurth, Jimmy Whitworth, Frances Gotch, Pontiano Kaleebu

    Published 2009-01-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Re-testing as a method of implementing external quality assessment program for COVID-19 real time PCR testing in Uganda.

    Re-testing as a method of implementing external quality assessment program for COVID-19 real time PCR testing in Uganda. by Erick Jacob Okek, Fredrick Joshua Masembe, Jocelyn Kiconco, John Kayiwa, Esther Amwine, Daniel Obote, Stephen Alele, Charles Nahabwe, Jackson Were, Bernard Bagaya, Stephen Balinandi, Julius Lutwama, Pontiano Kaleebu

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Case Reports of Human Monkeypox Virus Infections, Uganda, 2024

    Case Reports of Human Monkeypox Virus Infections, Uganda, 2024 by Nicholas Bbosa, Stella E. Nabirye, Hamidah S. Namagembe, Ronald Kiiza, Alfred Ssekagiri, Mary Munyagwa, Arafat Bwambale, Stephen Bagonza, Henry Kyobe Bosa, Robert Downing, Julius Lutwama, Pontiano Kaleebu, Deogratius Ssemwanga

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy.

    Duration of HIV-1 viral suppression on cessation of antiretroviral therapy in primary infection correlates with time on therapy. by Wolfgang Stöhr, Sarah Fidler, Myra McClure, Jonathan Weber, David Cooper, Gita Ramjee, Pontiano Kaleebu, Giuseppe Tambussi, Mauro Schechter, Abdel Babiker, Rodney E Phillips, Kholoud Porter, John Frater

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Thirteen-Year Sequelae of Marburg Virus Disease Survival: Persistent Cardiometabolic, Immunometabolic, and Haematological Alterations in the Absence of Psychological Morbidity

    Thirteen-Year Sequelae of Marburg Virus Disease Survival: Persistent Cardiometabolic, Immunometabolic, and Haematological Alterations in the Absence of Psychological Morbidity by Jennifer Serwanga, Raymond Ernest Kaweesa, Joseph Katende Ssebwana, Goeffrey Odoch, Raymond Reuel Wayesu, Anne Daphine Ntabadde, Deborah Mukisa, Peter Ejou, FiloStudy Team, Julius Julian Lutwama, Pontiano Kaleebu

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    High incidence of HIV-1 infection in a general population of fishing communities around Lake Victoria, Uganda.

    High incidence of HIV-1 infection in a general population of fishing communities around Lake Victoria, Uganda. by Noah Kiwanuka, Ali Ssetaala, Annet Nalutaaya, Juliet Mpendo, Matthias Wambuzi, Annet Nanvubya, Simon Sigirenda, Paul Kato Kitandwe, Leslie Elizabeth Nielsen, Apolo Balyegisawa, Pontiano Kaleebu, Josephine Nalusiba, Nelson Kaulukusi Sewankambo

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.

    High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the... by Cissy Kityo, Diana M Gibb, Charles F Gilks, Ruth L Goodall, Ivan Mambule, Pontiano Kaleebu, Deenan Pillay, Ronnie Kasirye, Peter Mugyenyi, A Sarah Walker, David T Dunn, DART Trial Team

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent.

    African AIDS vaccine programme for a coordinated and collaborative vaccine development effort on the continent. by Pontiano Kaleebu, Alash'le Abimiku, Shenaaz El-Halabi, Sinata Koulla-Shiro, Nicole Mamotte, Souleymane Mboup, Roy Mugerwa, John Nkengasong, Coumba Toure-Kane, Tim Tucker, Douglas Wassenaar, Carolyn Williamson, Dawit Wolday

    Published 2008-12-01
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort

    Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort by Gerald Kevin Oluka, Jackson Sembera, Joseph Ssebwana Katende, Violet Ankunda, Laban Kato, Ashwini Kurshan, Carl Graham, Jeffrey Seow, Katie J. Doores, Michael H. Malim, Julie M. Fox, Pontiano Kaleebu, Jennifer Serwanga

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles.

    Persistent and robust antibody responses to ChAdOx1-S Oxford-AstraZeneca (ChAdOx1-S, Covishield) SARS-CoV-2 vaccine observed in Ugandans across varied baseline immune profiles. by Jennifer Serwanga, Gerald Kevin Oluka, Claire Baine, Violet Ankunda, Jackson Sembera, Laban Kato, Joseph Ssebwana Katende, Geoffrey Odoch, Betty Oliver Auma, Ben Gombe, COVID-19 Immunoprofiling Team, Monica Musenero, Pontiano Kaleebu

    Published 2024-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: